Back
Goldman Sachs Nasdaq-100 Core Prm IncETF Vs. Longboard Pharmaceuticals Industry Stock Comparison
Buy
67
GPIQ
Goldman Sachs Nasdaq-100 Core Prm IncETF
Last Price:
48.84
Seasonality Move:
--
Buy
94
LBPH
Longboard Pharmaceuticals
Last Price:
32.25
Seasonality Move:
0.54%
Buy
67
Goldman Sachs Nasdaq-100 Core Prm IncETF (GPIQ)
is a Buy
Is Goldman Sachs Nasdaq-100 Core Prm IncETF a Buy, Sell or Hold?
- The current Goldman Sachs Nasdaq-100 Core Prm IncETF [GPIQ] share price is $48.83. The Score for GPIQ is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- GPIQ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
94
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $34.87. The Score for LBPH is 94, which is 88% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
GPIQ Stock Price Chart
What is Goldman Sachs Nasdaq-100 Core Prm IncETF's stock price today?
-
The Goldman Sachs Nasdaq-100 Core Prm IncETF share price today is $48.83
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPIQ is experiencing slight buying pressure.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $34.87
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
GPIQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.5 | Buy |
| Relative Strength Index (14 RSI): | 70.62 | Buy |
| Chaikin Money Flow: | 25915 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.89 - 48.35) | Buy |
| Bollinger Bands (100): | (45.09 - 47.33) | Buy |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.22 | Buy |
| Relative Strength Index (14 RSI): | 86.65 | Buy |
| Chaikin Money Flow: | 484372 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.64 - 26.62) | Buy |
| Bollinger Bands (100): | (17.72 - 23.42) | Buy |
GPIQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.27 | Buy |
| 20-day SMA: | 47.9 | Buy |
| 50-day SMA: | 46.66 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 48.33 | Buy |
| 20-day EMA: | 47.88 | Buy |
| 50-day EMA: | 47.04 | Buy |
| 200-day EMA: | 4.59 | Buy |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.37 | Buy |
| 20-day SMA: | 22.43 | Buy |
| 50-day SMA: | 21.05 | Buy |
| 200-day SMA: | 15.33 | Buy |
| 8-day EMA: | 28.7 | Buy |
| 20-day EMA: | 24.43 | Buy |
| 50-day EMA: | 21.77 | Buy |
| 200-day EMA: | 16.75 | Buy |
Goldman Sachs Nasdaq-100 Core Prm IncETF Earnings Growth & GPIQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.23 per share, an increase this year of $0.56 per share, and a decrease next year of $0.55 per share.
Goldman Sachs Nasdaq-100 Core Prm IncETF Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||